学术探索
学术期刊
新闻热点
数据分析
智能评审

The polypill and cardiovascular disease - May be appropriate for secondary, but perhaps notfor primary prevention

被引：15
作者：
Fahey, T [1 ]
Brindle, P
Ebrahim, S
机构：
[1] Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4AD, Scotland
[2] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2005年 / 330卷 / 7499期
关键词：
D O I：
10.1136/bmj.330.7499.1035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1035 / 1036
页数：2
相关论文
共 13 条
  • [1] Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis
    Clarke, R
    Collins, R
    Lewington, S
    Donald, A
    Alfthan, G
    Tuomilehto, J
    Arnesen, E
    Bonaa, K
    Blacher, J
    Boers, GHJ
    Bostom, A
    Bots, ML
    Grobee, DE
    Brattström, L
    Breteler, MMB
    Hofman, A
    Chambers, JC
    Kooner, JS
    Coull, BM
    Evans, RW
    Kuller, LH
    Evers, S
    Folsom, AR
    Freyburger, G
    Parrot, F
    Genst, J
    Dalery, K
    Graham, IM
    Daly, L
    Hoogeveen, EK
    Kostense, PJ
    Stehouwer, CDA
    Hopknis, PN
    Jacques, P
    Selhub, J
    Luft, FC
    Jungers, P
    Lindgren, A
    Lolin, YI
    Loehrer, F
    Fowler, B
    Mansoor, MA
    Malinow, MR
    Ducimetiere, P
    Nygard, O
    Refsum, H
    Vollset, SE
    Ueland, PM
    Omenn, GS
    Beresford, SAA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16): : 2015 - 2022
  • [2] Eidelman R, 2005, ARCH INTERN MED, V163, P2006
  • [3] Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism:: prospective and case-control studies from the Copenhagen City Heart Study
    Frederiksen, J
    Juul, K
    Grande, P
    Jensen, GB
    Schroeder, TV
    Tybjærg-Hansen, A
    Nordestgaard, BG
    [J]. BLOOD, 2004, 104 (10) : 3046 - 3051
  • [4] Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease - Randomized and observational comparisons of secondary prevention trials and their meta-analyses
    Hennekens, CH
    Sacks, FM
    Tonkin, A
    Jukema, JW
    Byington, RP
    Pitt, B
    Berry, DA
    Berry, SM
    Ford, NF
    Walker, AJ
    Natarajan, K
    Sheng-Lin, C
    Fiedorek, FT
    Belder, R
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (01) : 40 - 44
  • [5] Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis
    Hippisley-Cox, J
    Coupland, C
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7499): : 1059 - 1063
  • [6] Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?
    Lawlor, DA
    Smith, GD
    Bruckdorfer, KR
    Kundu, D
    Ebrahim, S
    [J]. LANCET, 2004, 363 (9422) : 1724 - 1727
  • [7] The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis
    Montgomery, AA
    Fahey, T
    Ben-Shlomo, Y
    Harding, J
    [J]. JOURNAL OF HYPERTENSION, 2003, 21 (09) : 1753 - 1759
  • [8] The middle-aged and older American: Wrong prototype for a preventive polypill?
    Mulrow, C
    Kussmaul, W
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (06) : 467 - 468
  • [9] A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women
    Ridker, PM
    Cook, NR
    Lee, IM
    Gordon, D
    Gaziano, JM
    Manson, JE
    Hennekens, CH
    Buring, JE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (13) : 1293 - 1304
  • [10] Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death - The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial
    Toole, JF
    Malinow, MR
    Chambless, LE
    Spence, JD
    Pettigrew, LC
    Howard, VJ
    Sides, EG
    Wang, CH
    Stampfer, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (05): : 565 - 575
12